Ligand validation:5XA3

PHE: PHENYLALANINE

PHE is a Ligand Of Interest in 5XA3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XA3_PHE_B_505	75%	37%	0.101	0.933	1.73	0.75	1	-	0	0	100%	1
5XA3_PHE_C_505	68%	39%	0.101	0.911	1.7	0.73	1	-	0	0	100%	1
5XA3_PHE_A_505	60%	37%	0.131	0.916	1.77	0.73	1	-	0	0	100%	1
5XA3_PHE_D_505	57%	36%	0.135	0.909	1.77	0.76	1	-	0	0	100%	1
8JC3_PHE_A_504	51%	57%	0.156	0.911	0.68	0.95	-	1	0	0	100%	0.6458
8JC4_PHE_A_504	16%	61%	0.272	0.846	0.68	0.82	-	-	1	0	100%	0.5
5FII_PHE_C_901	95%	64%	0.068	0.973	0.58	0.78	-	1	0	0	100%	1
5DCB_PHE_D_405	94%	60%	0.073	0.97	0.92	0.61	1	-	0	0	100%	1
3DES_PHE_B_412	93%	67%	0.073	0.969	0.73	0.54	-	-	1	0	100%	1
6YU3_PHE_A_703	92%	46%	0.088	0.98	1.15	0.95	1	1	0	0	100%	1
2VBW_PHE_A_1153	90%	40%	0.095	0.978	1.31	1.04	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.